ab-sa01
Biologicalexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2016 (NCT02757755)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- BacteriophageOTHER
Bacteriophage other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ab-sa01
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02757755 | Phase 1 | May 1, 2016 | AmpliPhi Biosciences Corporation, United States Army |
| NCT03395769 | N/A | — | AmpliPhi Biosciences Corporation |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AmpliPhi Biosciences Corporation | For profit | 2 | 2 | 2 | 2016 |
| United States Army | Government | 1 | 0 | 1 | 2016 |
2 organizations
Page 1 / 1